A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2002
12/12/2002	WO2002059065A3 Oligo or polyalkylene glycol-coupled thrombin inhibitors
12/12/2002	WO2002058534A3 Compositions and methods for the therapy and diagnosis of colon cancer
12/12/2002	WO2002053723A3 Degradation and detection of tse infectivity
12/12/2002	WO2002053288A3 A method for the manufacture of compositions containing low concentrations of salts
12/12/2002	WO2002053169A3 Use of dipeptylpeptidase iv and aminopeptidase-n inhibitors in the treatment of ischaemia-induced neuro-degeneration
12/12/2002	WO2002050106A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r4
12/12/2002	WO2002044718A3 S.aureus protein staau r2, gene encoding it and uses thereof
12/12/2002	WO2002036774A3 Derivatives of the human macrophage-migration inhibition factor (mif) and use thereof in pharmaceutical preparations in screening methods or the identification of analogues, agonists and antagonists
12/12/2002	WO2002033090A3 Pharmaceutical preparations and methods for inhibiting tumors
12/12/2002	WO2002032942A3 Compositions and methods for modulating rsv infection and immunity
12/12/2002	WO2002032463A9 Methods of treating cancers by stimulating dendritic cells or lymphomas with certain tnf molecules
12/12/2002	WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2002029040A3 25219, a novel human aminotransferase and uses therefor
12/12/2002	WO2002026784A3 Matrix proteins m1 and m2 of infections salmon anaemia virus
12/12/2002	WO2002026566A3 Container tracking system
12/12/2002	WO2002024899A3 Improved system for regulation of transgene expression
12/12/2002	WO2002018593A3 Modulation of fas and fasl expression
12/12/2002	WO2002018439A3 52991, a human transporter protein and uses therefor
12/12/2002	WO2002013843A3 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours
12/12/2002	WO2002008292A3 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
12/12/2002	WO2002002775A3 Calpain protease 12
12/12/2002	WO2002000246A8 Preparation containing an oxygen carrier for regeneration of the skin in the case of oxygen deficiency
12/12/2002	WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002	WO2001097607A3 Transgenic animal model of neurodegenerative disorders
12/12/2002	WO2001093983A9 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/12/2002	WO2001092497A9 Human pancreatic islet glucose-6-phosphatase
12/12/2002	WO2001090309A9 Peptides that stimulate mycobacterial growth
12/12/2002	WO2001089568A9 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
12/12/2002	WO2001083695A9 Dna sequences encoding dystrophin minigenes and methods of use thereof
12/12/2002	WO2001018207A9 Human 7tm proteins receptors and polynucleotides encoding the same
12/12/2002	WO2001012816A9 Porcine endovirus gag and env and diagnostic uses thereof
12/12/2002	WO2000032152A3 Compositions and methods for regulating bacterial pathogenesis
12/12/2002	US20020188248 Needleless syringe using super sonic gas flow for particle delivery
12/12/2002	US20020188212 High throughput biological heart rate monitor that is molecularly determined
12/12/2002	US20020188134 Pharmaceutical compositions
12/12/2002	US20020188110 Transforming growth factor alpha HI
12/12/2002	US20020188109 Expression vector for use transformation of yeast cells
12/12/2002	US20020188107 Plant protein for use in the treatment of cancer
12/12/2002	US20020188106 Tau protein epitopes for use in the treatment of alzheimer's disease
12/12/2002	US20020188103 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof
12/12/2002	US20020188102 Peptide for use as microbiocides
12/12/2002	US20020188101 Conjugated peptide nucleic acids having enhanced cellular uptake
12/12/2002	US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002	US20020187993 Bifunctional energy-reversible acyl-compositions
12/12/2002	US20020187992 Prodrugs via acylation with cinnamate
12/12/2002	US20020187980 Methods using PTPase inhibitors and insulin
12/12/2002	US20020187977 Methods for restoring cognitive function following systemic stress
12/12/2002	US20020187972 Methods for modulating expression of exogenous genes in mammalian systems
12/12/2002	US20020187954 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth
12/12/2002	US20020187953 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
12/12/2002	US20020187950 Keratinocyte derived interferon
12/12/2002	US20020187949 High throughput biological heart rate monitor that is molecularly determined
12/12/2002	US20020187948 Implantation of biological pacemaker that is molecularly determined
12/12/2002	US20020187947 Inflammation-related gene
12/12/2002	US20020187946 Mammalian iap gene family, primers, probes and detection methods
12/12/2002	US20020187939 Use of inhibitors of the renin-angiotensin system
12/12/2002	US20020187938 Ghrelin antagonists
12/12/2002	US20020187937 Immunosuppressant agonists
12/12/2002	US20020187936 Methods of treating liver disease and liver damage with growth hormone and foxM1B
12/12/2002	US20020187934 Peptide derivatives
12/12/2002	US20020187933 Cardiovascular disorders; regeneration of heart tissue
12/12/2002	US20020187932 Administering melanocortin receptor antagonist
12/12/2002	US20020187931 Modulating cell survival by modulating huntingtin function
12/12/2002	US20020187930 Substances and their uses
12/12/2002	US20020187927 Method for inhibiting apoptosis
12/12/2002	US20020187926 Combined use of derivatives of GLP-1 analogs and PPAR ligands
12/12/2002	US20020187924 Adjusting Rna translation
12/12/2002	US20020187923 Antidiabetic agent; hyperglycemic agents
12/12/2002	US20020187922 Novel molecules of the pyrin domain protein family and uses thereof
12/12/2002	US20020187542 Fatty-acid amide hydrolase
12/12/2002	US20020187536 Enzymatic polypeptide for use in treating lactose intolerance
12/12/2002	US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002	US20020187526 Neutrokine-alpha binding proteins and methods based thereon
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187520 Allergen/ inflammatory testing and diagnosis
12/12/2002	US20020187502 Detecting colon carcinoma in humans; obtain tissue sample, monitor expression of preferential genes, compare to control, evaluate for cancer
12/12/2002	US20020187494 PAR-3 compounds for therapy and diagnosis and methods for using same
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187473 Polyamide nucleic acid derivatives, and agents and processes for preparing them
12/12/2002	US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002	US20020187471 Novel telomerase
12/12/2002	US20020187206 Method and apparatus for fractional separation of proteins from plant material
12/12/2002	US20020187200 Dietary supplement comprising lactoferrin and citrus pectin
12/12/2002	US20020187196 Capsules capsules actic-co-glycolic copolymer to which a citric ester plasticizer has been incorporated and which contain a peptide drug within them.
12/12/2002	US20020187164 Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
12/12/2002	US20020187161 H. pylori antigens
12/12/2002	US20020187160 Vaccine delivery system
12/12/2002	US20020187159 The use of heat shock protein 70 preparations in vaccination against cancer and infectious disease
12/12/2002	US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002	US20020187153 Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cells
12/12/2002	US20020187151 Administering to the mammalian host a composition comprising a multivalent NKG2D-binding agent to a tumor expressing native NKG2D
12/12/2002	US20020187150 Preventive and/or therapeutic agent for systemic lupus erythematosus comprising anti-IL-6 receptor antibody as an active ingredient
12/12/2002	US20020187149 Activity-inhibiting amount of a growth factor neutralising agent or agents specific against only fibrotic growth factors together with a pharmaceutically acceptible carrier.
12/12/2002	US20020187148 T cell receptor ligands and methods of using same
12/12/2002	US20020187146 Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens
12/12/2002	US20020187145 Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
12/12/2002	US20020187142 Crosslinking of these receptors with a bispecific molecule of the invention would lead to inhibition of the release of allergic mediators and amelioration of the symptoms of allergic diseases.
12/12/2002	US20020187141 Composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent; determination whether the failure of traditional chemotherapy is due to multidrug resistant tumor cells
12/12/2002	US20020187140 Two novel human cathepsin proteins

1 ... 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 ... 3163